Depletion of Hsa_circ_0000144 Suppresses Oxaliplatin Resistance of Gastric Cancer Cells by Regulating MiR-502-5p/ADAM9 Axis

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2021 Apr 28

PMID 33907420

Citations 11

Authors

Haifeng Gao

Jiajia Xu

Fen Qiao

Liangjun Xue

Affiliations

Soon will be listed here.

Abstract

Background: Circular RNAs (circRNAs) have been disclosed to exert important roles in human cancers, including gastric cancer (GC). CircRNA hsa_circ_0000144 was identified as an oncogene in GC development. The aim of our study was to explore the role of hsa_circ_0000144 in oxaliplatin (OXA) resistance of GC.

Methods: Expression levels of hsa_circ_0000144, microRNA-502-5p (miR-502-5p) and A disintegrin and metalloproteinase 9 (ADAM9) were examined by quantitative real-time PCR (RT-qPCR) or Western blot assay. The OXA resistance of GC cells was evaluated by Cell Counting Kit-8 (CCK-8) assay. Colony formation assay was performed to assess the colony formation capacity. Cell apoptosis was determined by flow cytometry and caspase 3 activity. And cell migration and invasion were detected by Transwell assay. Target association between miR-502-5p and hsa_circ_0000144 or ADAM9 was demonstrated by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. Moreover, role of hsa_circ_0000144 in vivo was analyzed by xenograft tumor assay.

Results: Hsa_circ_0000144 and ADAM9 were highly expressed, while miR-502-5p was downregulated in OXA-resistant GC tissues and cells. Depletion of hsa_circ_0000144 could inhibit OXA resistance, proliferation and metastasis in OXA-resistant GC cells, which was attenuated by miR-502-5p inhibition. Hsa_circ_0000144 sponged miR-502-5p to positively regulate ADAM9 expression. MiR-502-5p suppressed OXA resistance, proliferation and metastasis in OXA-resistant GC cells by targeting ADAM9. Hsa_circ_0000144 knockdown could hamper tumor growth in vivo.

Conclusion: Hsa_circ_0000144 exerted inhibitory effects on OXA resistance, proliferation and metastasis of OXA-resistant GC cells by regulating miR-502-5p/ADAM9 axis, at least in part.

Citing Articles

Emerging roles of circular RNAs in tumorigenesis, progression, and treatment of gastric cancer.

Ma Q, Yang F, Xiao B, Guo X J Transl Med. 2024; 22(1):207.

PMID: 38414006 PMC: 10897999. DOI: 10.1186/s12967-024-05001-4.

Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen.

Zhang Y, Chao F, Lv L, Li M, Shen Z J Cancer Res Clin Oncol. 2023; 149(17):15365-15382.

PMID: 37639013 PMC: 10620281. DOI: 10.1007/s00432-023-05317-6.

CircRNA: A new class of targets for gastric cancer drug resistance therapy.

Zheng Y, Li Z, Wang Y, Chen W, Lin Y, Guo J Pathol Oncol Res. 2023; 29:1611033.

PMID: 37065861 PMC: 10097900. DOI: 10.3389/pore.2023.1611033.

The critical role of circular RNAs in drug resistance in gastrointestinal cancers.

Tehrani S, Esmaeili F, Shirzad M, Goodarzi G, Yousefi T, Maniati M Med Oncol. 2023; 40(4):116.

PMID: 36917431 DOI: 10.1007/s12032-023-01980-4.

Circular RNA hsa_circ_0000144 aggravates ovarian Cancer progression by regulating ELK3 via sponging miR-610.

Wu D, Liu J, Yu L, Wu S, Qiu X J Ovarian Res. 2022; 15(1):113.

PMID: 36243865 PMC: 9569040. DOI: 10.1186/s13048-022-01048-3.

References

Yin H, Wang Q, Huang X, Wang N, Yuan M, Wu D . Circ_0032627 accelerates proliferation of gastric cancer cells through regulating miR-502-5p expression. Eur Rev Med Pharmacol Sci. 2020; 24(12):6674-6681. DOI: 10.26355/eurrev_202006_21654. View

Ying Y, Li J, Xie H, Yan H, Jin K, He L . CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer. Cell Prolif. 2020; 53(2):e12751. PMC: 7048215. DOI: 10.1111/cpr.12751. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Wang B, Yang H, Shen L, Wang J, Pu W, Chen Z . Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development. Cell Physiol Biochem. 2016; 40(1-2):391-399. DOI: 10.1159/000452554. View

Shang Q, Yang Z, Jia R, Ge S . The novel roles of circRNAs in human cancer. Mol Cancer. 2019; 18(1):6. PMC: 6325800. DOI: 10.1186/s12943-018-0934-6. View

Apps M, Choi E, Wheate N . The state-of-play and future of platinum drugs. Endocr Relat Cancer. 2015; 22(4):R219-33. DOI: 10.1530/ERC-15-0237. View

Carl-McGrath S, Lendeckel U, Ebert M, Roessner A, Rocken C . The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol. 2004; 26(1):17-24. View

Sun L, Wang J, Zhao Z, Liu N, Wang A, Ren H . Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2. Oncol Rep. 2014; 31(5):2085-92. DOI: 10.3892/or.2014.3105. View

Wu Q, Wang H, Liu L, Zhu K, Yu W, Guo J . Hsa_circ_0001546 acts as a miRNA-421 sponge to inhibit the chemoresistance of gastric cancer cells via ATM/Chk2/p53-dependent pathway. Biochem Biophys Res Commun. 2019; 521(2):303-309. DOI: 10.1016/j.bbrc.2019.10.117. View

10.

Biagioni A, Skalamera I, Peri S, Schiavone N, Cianchi F, Giommoni E . Update on gastric cancer treatments and gene therapies. Cancer Metastasis Rev. 2019; 38(3):537-548. DOI: 10.1007/s10555-019-09803-7. View

11.

Wei J, Wang J, Gao X, Qi F . Identification of differentially expressed circRNAs and a novel hsa_circ_0000144 that promote tumor growth in gastric cancer. Cancer Cell Int. 2019; 19:268. PMC: 6794874. DOI: 10.1186/s12935-019-0975-y. View

12.

Peng X, Wu M, Liu W, Guo C, Zhan L, Zhan X . miR-502-5p inhibits the proliferation, migration and invasion of gastric cancer cells by targeting SP1. Oncol Lett. 2020; 20(3):2757-2762. PMC: 7399809. DOI: 10.3892/ol.2020.11808. View

13.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

14.

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

15.

Chen L, Yang L . Regulation of circRNA biogenesis. RNA Biol. 2015; 12(4):381-8. PMC: 4615371. DOI: 10.1080/15476286.2015.1020271. View

16.

Li X, Sun X, Xu H, Pan H, Liu Y, He L . Circ_ORC2 enhances the regulatory effect of miR-19a on its target gene PTEN to affect osteosarcoma cell growth. Biochem Biophys Res Commun. 2019; 514(4):1172-1178. DOI: 10.1016/j.bbrc.2019.04.188. View

17.

Huang W, Lu Y, Wang F, Huang X, Yu Z . Downregulation of circular RNA hsa_circ_0000144 inhibits bladder cancer progression via stimulating miR-217 and suppressing RUNX2 expression. Gene. 2018; 678:337-342. DOI: 10.1016/j.gene.2018.08.036. View

18.

Fang X, Bai Y, Zhang L, Ding S . Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia. Biosci Rep. 2020; 40(6). PMC: 7313448. DOI: 10.1042/BSR20201275. View

19.

Song W, Qian Y, Zhang M, Wang H, Wen X, Yang X . The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer. Eur Rev Med Pharmacol Sci. 2020; 24(6):3049-3061. DOI: 10.26355/eurrev_202003_20669. View

20.

Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L . Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020; 19(1):62. PMC: 7081551. DOI: 10.1186/s12943-020-01185-7. View